How These Guys Made $2B+ In 6 Years

My First MillionAbout 2 min readMay 19, 2025Watch original
THE SUMMARYAI-generated

Key Concepts:

  • Vaping as a smoking cessation tool
  • Valuation and investment
  • Black market vape liquids and health risks (popcorn lung)
  • FDA approval as a regulatory play
  • Acquisition by Altria

Investment in Enjoy and Initial Valuation

The speaker invested $2.5 million in a company called Enjoy, which was focused on using vaping as a method to help people quit smoking. The company emerged from bankruptcy with an initial valuation of $60 million. The speaker's investment was based on the observation that his friends were successfully using Enjoy's vape products to quit smoking.

Health Crisis and Black Market Liquids

Approximately three years into the investment, a significant health crisis emerged involving young people being hospitalized with "popcorn lung" and even dying. This was attributed to black market vape liquids, not the products manufactured by Enjoy or its CEO, Joel. These unregulated liquids were causing severe health damage.

FDA Approval Strategy and Regulatory Play

Despite the negative publicity surrounding vaping, Enjoy's CEO, Ryan, and Joel, viewed the situation as an opportunity. They recognized the potential for FDA approval as a strategic advantage. Their vision was to become one of the few companies with FDA approval for smoking cessation products, essentially turning the business into a "regulatory play."

Acquisition by Altria and Return on Investment

After five to seven years and an investment of $80 to $100 million, Enjoy successfully obtained FDA regulatory approval. Subsequently, the company was acquired by Altria for $2.2 billion. This resulted in a 30x return on the speaker's initial $2.5 million investment.

Synthesis/Conclusion:

The investment in Enjoy highlights the potential for high returns in emerging markets, but also the significant risks associated with regulatory uncertainty and public health concerns. The company's success was ultimately driven by its strategic focus on obtaining FDA approval, which transformed it into a valuable asset for acquisition by a major player in the tobacco industry. The speaker's experience underscores the importance of visionary leadership and adaptability in navigating complex regulatory landscapes.

AI summaries can miss context or contain errors. Check important details against the original video.

Go a little deeper.

Have a question about this video? Load its transcript to open the video chat.